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Evidence accumulates linking obesity and diabetes with cognitive dysfunction. At present
the mechanism(s) underlying these associations and the relative contribution of diet,
adiposity, and metabolic dysfunction are unknown. In this perspective key gaps in
knowledge are outlined and an initial sketch of a neuropsychological profile is developed
that points toward a critical role for dopamine (DA) adaptations in neurocognitive
impairment secondary to diabetes and obesity. The precise mechanisms by which
diet, metabolic dysfunction, and adiposity influence the DA system to impact cognition
remains unclear and is an important direction for future research.
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NEUROCOGNITIVE IMPAIRMENTS IN TYPE 2 DIABETES (T2D)
T2D is associated with cognitive decline, brain dysfunction, and dementia (Biessels et al., 2014;
Koekkoek et al., 2015; Stoeckel et al., 2016). One recent study estimated that the combined overall
relative risk for dementia is 73% higher in people with, compared to without T2D, indicating that
between 1 in 10 and 1 in 15 incidences of dementia may be attributable to T2D (Biessels et al.,
2014). Although glucose intolerance is diagnostic of T2D, a recent systematic review of 86 papers
examining T2D and cognition only reported a weak association between glycaemia, and cognition
(Geijselaers et al., 2015) and there is even less evidence for an association with other measures of
peripheral glucose regulation and cognitive function (e.g., insulin concentration, insulin action,
insulin resistance) (Geijselaers et al., 2015). Thus, although T2D is by definition associated with
altered glucose metabolism, it is not clear that altered glucose metabolism contributes to cognitive
change. The mechanism behind the link between cognitive dysfunction and T2D is therefore not
clear.
NEUROCOGNITIVE DEFICITS MAY ARISE FROM CHRONIC
CONDITIONS ASSOCIATED WITH T2D
The majority of human studies linking T2D to cognitive decline are performed in older individuals
with long-standing diagnoses of diabetes (Stoeckel et al., 2016). This poses a problem for
interpreting the pathophysiology of the link between T2D and cognition because individuals with
chronic T2D exhibit a number of pathologies associated with cognitive decline such as damage
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to the blood brain barrier (BBB), neuroinflammation (Banks
et al., 2012; Steculorum et al., 2014), cerebral atrophy, and small
vessel disease (Biessels and Reijmer, 2014; Akrivos et al., 2015;
Ramos-Rodriguez et al., 2016; Stranahan et al., 2016). The co-
occurrence of these pathologies that are secondary to diabetes
has led to controversy over whether it is T2D (Biessels and
Reagan, 2015) or complications arising from T2D that leads to
cognitive decline (De Felice and Ferreira, 2014). To rule-out
confounds associated with the secondary complications of T2D
it will be informative to study cognition in populations free from
other chronic conditions and in populations prior to the onset
of T2D. For example, it would be informative to characterize
neurocognition in youth before and after the onset of prediabetes,
since this population will be free from other chronic conditions
that could influence cognitive function.
IT IS UNKNOWN IF NEUROCOGNITIVE
DEFICITS ARE ASSOCIATED WITH T2D OR
ADIPOSITY OR BOTH
Perhaps the most important limitation of the current literature
is the failure to disentangle effects of metabolic dysfunction
on cognition from those of adiposity and diet. Obesity has
been associated with altered brain structure and function in
animal models and in metabolically and neurologically healthy
adults and children (Elias et al., 2003; Reinert et al., 2013;
Hsu and Kanoski, 2014; Yau et al., 2014; Bocarsly et al.,
2015), while diets high in saturated fat and cholesterol are
correlated with compromised cognitive flexibility and processing
speed in pre-pubertal children after adjusting for age, sex,
socioeconomic status, IQ, VO2max, and BMI (Khan et al., 2015b).
Consumption of a high fat diet (HFD) can also negatively
impact brain and brain function well-before obesity onset. For
example, in animal models hypothalamic insulin resistance is
observed following acute exposure to HFD before changes in
adiposity occur (Clegg et al., 2011) and impaired performance on
hippocampal-dependent tasks is observed after only 72-h access
to a HFD when animals have actually lost weight, presumably
due to neophobia (Kanoski and Davidson, 2010). These findings
suggest that obesity can impact cognition independently from
metabolic disease and that diet can impact metabolic function
and cognition independently of obesity.
To date, studies have rarely taken obesity and diet into account
when examining the relationship between T2D and cognition.
For example, patients with T2D exhibit reduced activity in
the default mode network (Musen et al., 2012), which has
been associated with a wide range of neurological conditions
and cognitive impairments (Browndyke et al., 2017; Contreras
et al., 2017; Jockwitz et al., 2017; von Rhein et al., 2017)
but BMI, which was higher in T2D, was not accounted for.
Similarly, the putative confound of glucose intolerance is often
not considered when examining the relationship between obesity
and cognition. For example, a prospective study examining
the impact of obesity on cognition excluded participants for
many medical conditions likely to influence cognition, including
stroke, dementia, myocardial infarction, and atrial fibrillation
but NOT diabetes (Gunstad et al., 2010). They did however,
include “glucose intolerance” in their mixed model regression
analyses and found that this variable was related to cognitive
impairments that also correlated with their adiposity measures
(waist-hip ratio). In another study deficits in executive function
and declarative memory were observed in 38 middle-aged adults
with insulin resistance but without T2D compared to 54 age,
gender, education but NOT BMI matched controls. Since the
insulin resistance group had significantly higher BMI these
deficits may be equally attributable to BMI (Bruehl et al., 2010).
Failure to account for confounds between diet, obesity, and
metabolic dysfunction also pervade the animal literature. Rats
prone to develop diabetes upon HFD are often used as a model
of T2D (Levin and Routh, 1996). These models have been
associated with deficits on the water maze (Li et al., 2002;
Stranahan et al., 2008b), object recognition test (Stranahan et al.,
2008a), contextual cue conditioning (Grillo et al., 2011), and
discrimination and reversal learning (Kanoski et al., 2007, 2010).
HFD has also been shown to increase inflammatory cytokines
and impair neuroplasticity and learning and memory in the
hippocampus (Erion et al., 2014). The extent to which adiposity
or insulin resistance contributed to these observations is not
known. However, impaired cognition is also observed with the
streptozotocin (STX)-induced diabetic model, which impairs
insulin production without increasing adiposity or requiring
a high fat diet, indicating that metabolic dysfunction alone is
sufficient to impair cognitive function (Stranahan et al., 2008a).
Importantly, when more than one variable is measured
interactions between adiposity, diet, and impaired glucose
tolerance are revealed. In obese humans without T2D, insulin
sensitivity mediates the relationship between working memory-
related activation in the right parietal cortex and BMI (Gonzales
et al., 2010), while brain insulin action is selectively impaired in
the prefrontal cortex in overweight and obese, but not diabetic
adults compared to their lean counterparts (Kullmann et al.,
2015), highlighting interactions between adiposity and glucose
tolerance on brain function.
In summary, the relative contribution of diet, impaired
glucose tolerance, and adiposity to neurocognitive impairment is
largely unexplored and unknown.
CHARACTERIZATION OF GLYCEMIA
Another factor clouding the association between T2D and
cognitive impairment is the use of a variety of methods
to characterize glycemia, each of which reflect different,
and sometimes independent, aspects of glucose metabolism
(Geijselaers et al., 2015). Insulin sensitivity can be measured
using a variety of techniques. HbA1c, which reflects the mean
glucose concentration over a period of 8–12 weeks is the most
frequently used measure. Fasting blood glucose concentrations
are also frequently measured, which reflect nocturnal hepatic
gluconeogenesis that is influenced by hepatic insulin sensitivity,
but a recent review found that studies often fail to report
whether measurements are taken at the same time of day
(Geijselaers et al., 2015). Other measures include post-prandial
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glucose concentrations, reflecting insulin secretory responses
and HOMA-IR to measure insulin resistance. HbA1c shows the
strongest association to insulin resistance, followed by post-
prandial measures. Fasting glucose, by contrast, seems to be
unrelated to cognitive performance (Geijselaers et al., 2015).
Interestingly, one study found that insulin resistance was related
to declarative memory whereas HbA1c was associated with
executive dysfunction (Bruehl et al., 2010), hinting at the
possibility that the different measures are associated with distinct
pathophysiological effects on the brain and highlighting the need
for more comprehensive measures of glucose metabolism.
NEUROCOGNITIVE IMPAIRMENTS MAY BE
RELATED TO CENTRAL RATHER THAN
(OR IN ADDITION TO) PERIPHERAL
IMPAIRMENTS IN GLUCOSE TOLERANCE
Insulin receptors are widely distributed in the brain, with the
highest concentrations in the olfactory bulb, hypothalamus,
cerebral cortex, cerebellum, and hippocampus (Havrankova
et al., 1978; van Houten et al., 1979). Brain-specific deletion
of the insulin receptor in mice results in glycogen synthase
kinase 2 beta activation resulting in hyperphosphorylation of
tau protein, a hallmark of early Alzheimer’s Disease (AD)
(Schubert et al., 2004). There is also evidence from animal studies
that disrupted central insulin and insulin-like growth factor-
1 (IGF-1) signaling may lead to disrupted neurotransmitter
(e.g., dopamine) and astroglial cell function, brain endothelial
cell function involved in formation and regulation of BBB,
mitochondrial metabolism and oxidative stress, clearance of
Aβ and/or amyloid fibrils, cholesterol synthesis in the brain
(important for myelination and membrane function), glucose
and lipidmetabolism in select regions of the brain, and regulation
of central energy balance, which could relate to both metabolic
and neurocognitive dysfunction (Brüning et al., 2000; Convit
et al., 2003; Schubert et al., 2004; Suzuki et al., 2010; Kleinridders
et al., 2014; Stouffer et al., 2015). While these data suggest a likely
role for central insulin resistance in impaired neurocognitive
function, it is important to note that central insulin resistance
has a complicated relationship with peripheral glycemic control
(Ketterer et al., 2011). Central insulin resistance is thought to
result from a combination of impaired insulin receptor signaling
and decreases in the transport of insulin across the BBB (Banks
et al., 2012), which can occur secondary to peripheral glucose
intolerance (Niswender et al., 2003). Conversely, central insulin
signaling contributes to peripheral glucose regulation (Brüning
et al., 2000; Heni et al., 2014) to create a dynamic brain-gut axis
regulating glucose metabolism. Importantly, however, central
insulin resistance can occur independently from peripheral
impairments in glucose tolerance. Post-mortem studies of brain
tissue from patients with AD but not T2D, reveal disrupted brain
insulin signaling (De Felice and Ferreira, 2014; Yarchoan and
Arnold, 2014). Accordingly, treatment with intranasal insulin,
which results in direct insulin transport from the nasal cavity
to the CNS via intraneuronal and extraneuronal pathways
(Reger and Craft, 2006), improves cognition in patients with
(Reger et al., 2008; Craft et al., 2012) and without (Hallschmid
et al., 2007, 2008) dementia. These findings underscore the
importance of concurrent measures of peripheral and central
insulin resistance.
One promising avenue for future research is in using
intranasal insulin in combination with neuroimaging
methodologies and neuropsychological testing to assess the
role of central insulin resistance in neurocognition (Tschritter
et al., 2006; Ketterer et al., 2011; Grichisch et al., 2012; Kullmann
et al., 2013, 2015; Heni et al., 2014, 2016). For example, intranasal
insulin decreases the blood oxygen dependent (BOLD) response
in the hypothalamus and PFC increases BOLD response in the
striatum (Schilling et al., 2014) and insular cortex (Heni et al.,
2012) and increases brain energy levels (Jauch-Chara et al.,
2012). Critically, these effects are blunted in obesity (Tschritter
et al., 2006) with evidence that hypothalamic insulin resistance is
driven by visceral fat and frontal insulin resistance by peripheral
insulin sensitivity (Kullmann et al., 2015). Collectively, these
findings indicate a complex relationship between peripheral
glucose control and central insulin resistance and they raise the
possibility that central insulin resistance contributes to cognitive
impairment in concert with, or independently from peripheral
impaired glucose tolerance.
NEUROCOGNITIVE DEFICITS MAY BE
DOMAIN-SPECIFIC AND DIFFERENTIALLY
INFLUENCED BY DIET, ADIPOSITY, AND
METABOLIC DYSFUNCTION
Although obesity and T2D are occasionally associated with global
measures of brain atrophy (Enzinger et al., 2005; Gunstad et al.,
2010; Raji et al., 2010; Brooks et al., 2013) and cognitive decline
(Liang et al., 2014), many studies suggest that executive function
is the domain most affected in both adults (Gunstad et al., 2007;
Sabia et al., 2009; Fitzpatrick et al., 2013) (Volkow et al., 2009)
and children (Convit et al., 2003; Reinert et al., 2013; Liang
et al., 2014). For example, negative correlations are observed
between BMI and performance on tasks of executive function
but not episodic verbal memory (Volkow et al., 2009) with
BMI negatively, and executive performance positively, correlated
with baseline prefrontal glucose metabolism. Similarly, a recent
meta-analysis of 21 studies concluded that obesity is associated
with impairments in decision-making, planning and problem
solving with less evidence for associations with verbal fluency and
learning and memory (Fitzpatrick et al., 2013). Correspondingly,
structural changes (Enzinger et al., 2005; Pannacciulli et al., 2006;
Raji et al., 2010; Fotuhi et al., 2012; Bocarsly et al., 2015) and
reduced brain connectivity (Musen et al., 2012) are observed in
the parietal and prefrontal cortex (PFC), which are critical for
executive function.
There is also strong evidence from animal work that HFD
produces hippocampal insulin resistance (Biessels and Reagan,
2015) and damage (Hsu and Kanoski, 2014), resulting in
impaired hippocampal-dependent cognitive functions (Kanoski
and Davidson, 2011). Likewise, hippocampal atrophy is observed
in obese humans (Raji et al., 2010) and altered hippocampal
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white matter connectivity is found in T2D (van Bussel et al.,
2016). However, there are inconsistent findings with respect to
alterations in hippocampal-dependent episodic memory tasks
(Fitzpatrick et al., 2013). For example, significant deficits in
working memory and in reinforcement learning are observed
in the absence of episodic learning and memory impairment,
in obese vs. healthy weight adults that are matched for age,
gender, education, and IQ (Coppin et al., 2014). In contrast,
impaired episodic memory and decreased hippocampal volume
is observed as a function of glucose tolerance (Convit et al.,
2003) and intranasal insulin increases the functional connectivity
between the hippocampus and PFC in people with T2D (Zhang
et al., 2015). Other studies report hippocampal-dependent
impairments as a function of saturated fat intake (Francis and
Stevenson, 2011) and central, but not whole body adiposity
(Khan et al., 2015a). Collectively these data suggest that episodic
memory may be affected by diet and metabolic dysfunction while
being unrelated to BMI and whole body obesity.
This emerging neuropsychological profile provides an
important insight into the pathophysiological mechanism
that gives rise to neurocognitive impairment in obesity and
T2D. Brain functions associated with diabetes and obesity
tend to rely upon DA signaling (Figure 1). For example, the
dopaminergic fronto-striatal loop plays a well-known role in
working memory, cognitive flexibility, reinforcement learning,
and incentive motivation (Frank and Fossella, 2011). It is also
critical for response inhibition, the failure of which is associated
with addictive like behaviors including overeating (Lokken
et al., 2009; Maayan et al., 2011; Lee et al., 2013; Guo et al.,
2014; Zhao et al., 2016). Finally, a role for DA in memory via a
projection from the ventral tegmental area to the hippocampus
has been described (Shohamy and Adcock, 2010). As reviewed
above, these DA-dependent cognitive processes are altered in
obesity/T2D, raising the possibility that a common pathway
by which diet, adiposity and metabolic dysfunction might
coalesce to impact cognition is by producing alterations in the
FIGURE 1 | This cartoon depicts alterations in DA signaling as a common link by which diet, adiposity, and metabolic dysfunction might impact
cognition, motivation, and energy balance. A variety of mechanisms at the cellular and molecular level could support this association by regulating pre and
post-synaptic DA receptor expression, DA synthesis, release, and reuptake. Alterations at any level may in turn have a wide impact on brain function and provide a
parsimonious explanation for a number of dysfunctions associated with obesity and T2D.
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DA system (Figure 1). Interestingly, although DA adaptations
are considered integral in the development of compulsive
behaviors and alterations in reward sensitivity they are not
typically considered as a potential mechanism behind other
neurocognitive complications in T2D and obesity.
There are consistent findings in the animal literature that
HFD, and adiposity alter DA signaling at the cellular, and
molecular levels (Anderzhanova et al., 2007; Johnson and Kenny,
2010; van de Giessen et al., 2012, 2013; Sharma and Fulton,
2013; Tellez et al., 2013; Cansell et al., 2014; Adams et al., 2015;
Woods et al., 2016), as well as mounting evidence for altered
DA signaling in human obesity, especially reflected in changes
in DA receptor density, (Wang et al., 2001, 2011; Dunn et al.,
2010; Steele et al., 2010; Eisenstein et al., 2013, 2015; Guo et al.,
2014; Cosgrove et al., 2015; Horstmann et al., 2015; Karlsson
et al., 2015; Caravaggio et al., 2015b; Dang et al., 2016; Gaiser
et al., 2016). Additionally, there is evidence that central and
peripheral insulin resistance might impact DA function. Central
insulin signaling, acting through the downstreammodulator Akt,
is a potent modulator of DA transporter (DAT) activity, which
fine-tunes DA signaling at the synapse (Kleinridders et al., 2015),
demonstrating a pathway by which central IR could influence the
DA system. Insulin administration also suppresses DA release
by clearing DA from the synapse and concomitantly reducing
the rewarding properties of food (Figlewicz and Sipols, 2010).
Likewise, peripheral insulin sensitivity is associated with reduced
endogenous DA levels (Murzi et al., 1996; Caravaggio et al.,
2015a) and peripheral glycemia with PFC-striatal-hippocampal
functional connectivity (Page et al., 2013). Thus, diet, adiposity,
and insulin resistance could each impact DA signaling with
the potential for additive effects and interactions. Future work
aiming to disambiguate the unique and interacting effects
will therefore be an important step toward understanding
neurocognitive impairment in T2D and obesity.
SUMMARY
In summary, a consensus is emerging that obesity and
diabetes are accompanied by cognitive impairments and brain
dysfunction and that at least some of these effects are
secondary to their onset. Multiple mechanisms have been
proposed to underlie these associations but at present it is
unclear which mechanism, or mechanisms, are critical. Also
unclear is whether diet, obesity and metabolic dysfunction
have distinct and/or converging pathways to neurocognitive
impairment. However, work emerges to suggest that all three
factors may influence DA signaling, which is provocative since
the cognitive impairments that characterize diabetes and obesity
uniformly rely upon the integrity of the DA system. It is
therefore proposed that adaptations in DA signaling secondary
to diet, adiposity and metabolic dysfunction underlie much
of the neurocognitive impairment observed in diabetes and
obesity.
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